A detailed history of Oracle Alpha Inc. transactions in Xencor Inc stock. As of the latest transaction made, Oracle Alpha Inc. holds 14,473 shares of XNCR stock, worth $304,077. This represents 0.57% of its overall portfolio holdings.

Number of Shares
14,473
Previous 14,526 0.36%
Holding current value
$304,077
Previous $308 Million 3.86%
% of portfolio
0.57%
Previous 0.4%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$18.65 - $26.52 $988 - $1,405
-53 Reduced 0.36%
14,473 $320 Million
Q4 2023

Feb 14, 2024

BUY
$16.53 - $21.42 $240,114 - $311,146
14,526 New
14,526 $308 Million

Others Institutions Holding XNCR

About Xencor Inc


  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $1.25B
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Oracle Alpha Inc. Portfolio

Follow Oracle Alpha Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oracle Alpha Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oracle Alpha Inc. with notifications on news.